Association of variants in RETN with plasma resistin levels and diabetes-related traits in the framingham offspring study

Diabetes

Volumn 58, Issue 3, 2009, Pages 750-756

  Hivert, Marie France ^a,b   Manning, Alisa K ^c   McAteer, Jarred B ^a,d   Dupuis, Josée ^c   Fox, Caroline S ^e,f   Cupples, L Adrienne ^c   Meigs, James B ^a,b   Florez, Jose C ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f FRAMINGHAM HEART STUDY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RESISTIN;

3' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; BIOLOGICAL TRAIT; BODY MASS; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETN GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; BLOOD; BODY HEIGHT; BODY WEIGHT; CLINICAL TRIAL; FOLLOW UP; GENETICS; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; PEDIGREE; PHENOTYPE; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; UNITED STATES; WAIST CIRCUMFERENCE;

AGED; BODY HEIGHT; BODY WEIGHT; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; MIDDLE AGED; PEDIGREE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PROPORTIONAL HAZARDS MODELS; RESISTIN; WAIST CIRCUMFERENCE;

EID: 62749124321     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1339     Document Type: Article

References (40)

1. Scherer PE: Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55:1537-1545, 2006
2. McTernan PG, Kusminski CM, Kumar S: Resistin. Curr Opin Lipidol 17:170-175, 2006
3. Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature 409:307-312, 2001
4. Fain JN, Cheema PS, Bahouth SW: Resistin release by human adipose tissue explants in primary culture. Biochem Biophys Res Commun 300: 674 -678, 2003
5. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 309:286-290, 2003
6. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 300:472-476, 2003
7. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr: Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112:1796-1808, 2003
8. Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL: Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 156:279-284, 2007
9. Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Kohara K, Miki T, Makino H: Plasma resistin, associated with single nucleotide polymorphism-420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 30:1501-1506, 2007
10. Hivert MF, Sullivan LM, Fox CS, Nathan DM, D'Agostino RB Sr, Wilson PW, Meigs JB: Associations of adiponectin, resistin, and TNF{alpha} with insulin resistance. J Clin Endocrinol Metab 93:3165-3172, 2008
11. Menzaghi C, Coco A, Salvemini L, Thompson R, De Cosmo S, Doria A, Trischitta V: Heritability of serum resistin and its genetic correlation with insulin resistance-related features in nondiabetic Caucasians. J Clin Endocrinol Metab 91:2792-2795, 2006
12. Azuma K, Oguchi S, Matsubara Y, Mamizuka T, Murata M, Kikuchi H, Watanabe K, Katsukawa F, Yamazaki H, Shimada A, Saruta T: Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm Metab Res 36:564-570, 2004
13. Cho YM, Youn BS, Chung SS, Kim KW, Lee HK, Yu KY, Park HJ, Shin HD, Park KS: Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 47:559-565, 2004
14. Osawa H, Onuma H, Ochi M, Murakami A, Yamauchi J, Takasuka T, Tanabe F, Shimizu I, Kato K, Nishida W, Yamada K, Tabara Y, Yasukawa M, Fujii Y, Ohashi J, Miki T, Makino H: Resistin SNP-420 determines its monocyte mRNA and serum levels inducing type 2 diabetes. Biochem Biophys Res Commun 335:596 -602, 2005
15. Bouchard L, Weisnagel SJ, Engert JC, Hudson TJ, Bouchard C, Vohl MC, Perusse L: Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J Endocrinol Invest 27:1003-1009, 2004
16. Engert JC, Vohl M-C, Williams SM, Lepage P, Faith J, Dore C, Renaud Y, Burtt NP, Villeneuve A, Hirschhorn JN, Altshuler D, Groop LC, Despres J-P, Gaudet D, Hudson TJ: 5′ flanking variants of resistin are associated with obesity. Diabetes 51:1629-1634, 2002
17. Mattevi VS, Zembrzuski VM, Hutz MH: A resistin gene polymorphism is associated with body mass index in women. Hum Genet 115:208-212, 2004
18. Norata GD, Ongari M, Garlaschelli K, Tibolla G, Grigore L, Raselli S, Vettoretti S, Baragetti I, Noto D, Cefalu AB, Buccianti G, Averna M, Catapano AL: Effect of the -420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. J Intern Med 262:104-112, 2007
19. Smith SR, Bai F, Charbonneau C, Janderova L, Argyropoulos G: A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52:1611-1618, 2003
20. Ukkola O, Kesaniemi YA, Tremblay A, Bouchard C, Kesaniemi YA: Two variants in the resistin gene and the response to long-term overfeeding. Eur J Clin Nutr 58:654-659, 2004
21. Xu JY, Sham PC, Xu A, Tso AWK, Wat NMS, Cheng KY, Fong CHY, Janus ED, Lam KSL: Resistin gene polymorphisms and progression of glycaemia in southern Chinese: a 5-year prospective study. Clin Endocrinol 66:211217, 2007
22. Pizzuti A, Argiolas A, Di Paola R, Baratta R, Rauseo A, Bozzali M, Vigneri R, Dallapiccola B, Trischitta V, Frittitta L: An ATG repeat in the 3′ - untranslated region of the human resistin gene is associated with a decreased risk of insulin resistance. J Clin Endocrinol Metab 87:4403-4406, 2002
23. Conneely KN, Silander K, Scott LJ, Mohlke KL, Lazaridis KN, Valle TT, Tuomilehto J, Bergman RN, Watanabe RM, Buchanan TA, Collins FS, Boehnke M: Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia 47:1782-1788, 2004
24. Gouni-Berthold I, Giannakidou E, Faust M, Kratzsch J, Berthold HK, Krone W: Resistin gene 3′-untranslated region +62G->A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population. J Intern Med 258:518-526, 2005
25. Kunnari A, Ukkola O, Kesaniemi YA: Resistin polymorphisms are associated with cerebrovascular disease in Finnish type 2 diabetic patients. Diabet Med 22:583-589, 2005
26. Ochi M, Osawa H, Onuma H, Murakami A, Nishimiya T, Shimada F, Kato K, Shimizu I, Shishino K, Murase M, Fujii Y, Ohashi J, Makino H: The absence of evidence for major effects of the frequent SNP + 299G>A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes. Diabetes Res Clin Pract 61:191-198, 2003
27. Wang H, Chu WS, Hemphill C, Elbein SC: Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:2520-2524, 2002
28. Ma X, Warram JH, Trischitta V, Doria A: Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J Clin Endocrinol Metab 87:4407-4410, 2002
29. Ochi M, Osawa H, Hirota Y, Hara K, Tabara Y, Tokuyama Y, Shimizu I, Kanatsuka A, Fujii Y, Ohashi J, Miki T, Nakamura N, Kadowaki T, Itakura M, Kasuga M, Makino H: Frequency of the G/G genotype of resistin single nucleotide polymorphism at -420 appears to be increased in younger-onset type 2 diabetes. Diabetes 56:2834-2838, 2007
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
31. Gutt M, Davis CL, Spitzer SB, Llabre MM, Kumar M, Czarnecki EM, Schneiderman N, Skyler JS, Marks JB: Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 47:177-184, 2000
32. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O'Donnell CJ, Hoffmann U: Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography. Int J Obes 31:500-506, 2007
33. Nathan DM: Labile glycosylated hemoglobin contributes to hemoglobin A1 as measured by liquid chromatography or electrophoresis. Clin Chem 27:1261-1263, 1981
34. Almasy L, Blangero J: Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62:1198-1211, 1998
35. Therneau T, Grambsch P: Modeling Survival Data: Extending the Cox Model. New York, Springer, 2001
36. Therneau TM, Grambsch PM, Pankratz VS: Penalized survival models and frailty. J Comput Graph Stat 12:156-175, 2003
37. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
38. Yamauchi J, Osawa H, Takasuka T, Ochi M, Murakami A, Nishida W, Onuma H, Takata Y, Tabara Y, Miki T, Ohashi J, Makino H: Serum resistin is reduced by glucose and meal loading in healthy human subjects. Metabolism 57:149-156, 2008
39. Osawa H, Yamada K, Onuma H, Murakami A, Ochi M, Kawata H, Nishimiya T, Niiya T, Shimizu I, Nishida W, Hashiramoto M, Kanatsuka A, Fujii Y, Ohashi J, Makino H: The G/G genotype of a resistin single-nucleotide polymorphism at -420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am J Hum Genet 75:678-686, 2004
40. Li K, Wang S-W, Li Y, Martin RE, Li L, Lu M, Lamhamedi-Cherradi S-E, Hu G, Demissie-Sanders S, Zheng J, Chung F, Oates T, Yao Z: Identification and expression of a new type II transmembrane protein in human mast cells. Genomics 86:68-75, 2005